Granted Patent B2

US 12,558,145 · App. 16/238,483 · Granted Feb 24, 2026

Inventors: James Boll (Montclair, NJ); Robert McCarthy (Maynard, MA); Bo Chen (Burlington, MA); Richard Shaun Welches (Woburn, MA); Daniel Masse (Windham, NH); Ali Shajii (Weston, MA); Michael Kishinevsky (North Andover, MA); David Sonnenshein (Boston, MA)

Assignee: CYNOSURE, LLC

A61B18/14A61B5/01A61B5/015A61B5/053A61B5/4833A61N1/403A61B2018/00023A61B2018/00113A61B2018/00136A61B2018/0016A61B2018/00172A61B2018/00291A61B2018/00452A61B2018/00458A61B2018/00464A61B2018/00488A61B2018/00559A61B2018/00577A61B2018/00589A61B2018/00625A61B2018/00642A61B2018/00779A61B2018/00791A61B2018/00827A61B2018/00875A61B2018/124A61B2018/1253A61B2018/126A61B2018/1467

Abstract

Claims (58)

1 . A method of controlling an RF-based treatment system, the method comprising:

selecting a length Y, wherein Y is a distance of signal transmission path from output of second node to an electrode of an electrode array or an input of applicator that incorporates the electrode array;

connecting a plurality of nodes of the RF-based treatment system, wherein a first node controls one or more parameters of an RF drive signal;

non-invasively contacting a skin surface with the electrode array;

synchronizing a second node and a third node with the first node, wherein first node, second node and third node are in electrical communication with a radiofrequency (RF) transmission line,

wherein the second node comprises distribution electronics and the third node comprises the electrode array,

wherein each electrode of the electrode array is an individually addressable treatment electrode;

transmitting control signals from first node to second node using serial communication protocol during an active treatment session,

wherein the active treatment session is a non-ablative and non-invasive treatment session, wherein the active treatment session comprises an impedance mapping performed using the electrode array in communication with the RF transmission line, wherein the signal transmission path having the length Y is a conductive trace on a printed circuit board, configured to improve impedance mapping and reduce cross coupling below a threshold level,

wherein the electrode array is controlled to direct RF energy for non-ablative tissue treatment;

measuring impedance values at one or more electrodes of the electrode array, within a region of tissue, during the active treatment session;

determining impedance changes of tissue beneath skin surface under one or more electrodes of the electrode array using one or more of the measured impedance values within the region of tissue to obtain an impedance mapping of the region of tissue;

determining a temperature of a tissue beneath the skin surface under one or more electrodes of the electrode array using one or more of the measured impedance values; and

controlling activation and deactivation of a plurality of electrodes of the electrode array during the active treatment session to achieve substantially uniform treatment of the tissue region using the impedance mapping and the determined temperature in response to one or more determined impedance changes.

2 . The method of claim 1 , further comprising phasing the second node using one or more output signals from the first node.

3 . The method of claim 1 , further comprising measuring current signals at one or more electrodes of the electrode array.

4 . The method of claim 1 , further comprising activating and deactivating an electrode using the second node.

5 . The method of claim 1 , wherein the active treatment session further comprises performing the impedance mapping using the electrode array in communication with one or both of a second electrode array and a drain pad.

6 . The method of claim 1 , further comprising mapping impedance mapping using the electrode array in communication with a second electrode.

7 . The method of claim 1 , wherein impedance mapping is performed before the active treatment session or after the active treatment session.

8 . The method of claim 1 , further comprising mapping impedance using the electrode array.

9 . The method of claim 1 , wherein the first node comprises an RF driver platform.

10 . The method of claim 1 , further comprising controlling, using the second node, transmission of one or more DC power signals.

11 . The method of claim 1 , further comprising transmitting an RF drive signal to or from the second node.

12 . The method of claim 11 , further comprising controlling, using the first or second node, phasing of an RF drive signal.

13 . The method of claim 1 , wherein Y is less than about 3 feet.

14 . The method of claim 1 , wherein Y ranges from about 1 foot to 2 feet.

15 . The method of claim 1 , further comprising determining a temperature of a tissue beneath the skin surface under one or more electrodes of the electrode array.

16 . The method of claim 15 , wherein determining the temperature of the tissue beneath the skin surface is performed using one or more of the measured impedance values.

17 . The method of claim 1 , wherein tissue beneath the skin surface is a subcutaneous volume of tissue under an electrode of the electrode array.

18 . The method of claim 17 , wherein the subcutaneous volume comprises fat.

19 . The method of claim 1 , further comprising isolating a patient from unsafe electric currents using the first node.

20 . The method of claim 1 , further comprising heating subcutaneous septae in response to heating connective tissue with RF energy, wherein the RF energy selectively heats septae within cellulite while substantially avoiding conduction of heat into adjacent tissue.

21 . The method of claim 1 , wherein the determined impedance changes are proportional to temperature changes in the tissue.

22 . The method of claim 21 , further comprising adjusting RF energy delivered by one or more electrodes of electrode array in response to differences in determined impedance changes to homogenize temperature of tissue under treatment below electrode array.

23 . The method of claim 1 , wherein the active treatment session is a selective tissue coagulation session, wherein the electrode array is controlled to direct RF energy for selective tissue coagulation treatment.

24 . The method of claim 1 , wherein the active treatment session is a skin tightening treatment session, wherein the electrode array is controlled to direct RF energy for skin tightening treatment.

25 . The method of claim 1 , further comprising reducing edge effects at periphery of one or more electrodes in the electrode array by grouping electrodes of the electrode array into clusters and selectively controlling the activation and deactivation of the clusters.

26 . A method of controlling an RF-based treatment system, the method comprising:

selecting a length Y, wherein Y is a distance of signal transmission path from output of second node to an electrode of an electrode array or an input of applicator that incorporates the electrode array;

connecting a plurality of nodes of the RF-based treatment system,

wherein a first node controls one or more parameters of an RF drive signal;

non-invasively contacting a skin surface with an electrode array;

synchronizing a second node and a third node with the first node,

wherein first node, second node and third node are in electrical communication with a radiofrequency (RF) transmission line,

wherein the second node comprises distribution electronics and the third node comprises the electrode array,

wherein each electrode of the electrode array is an individually addressable treatment electrode, the electrode array configured to direct RF energy for selective tissue coagulation,

wherein the second node is configured to measure current flowing out of each electrode of the electrode array;

transmitting control signals from first node to second node using serial communication protocol during an active treatment session,

wherein the active treatment session is a non-ablative and non-invasive treatment session, wherein the electrode array is controlled to direct RF energy for non-ablative tissue treatment;

measuring impedance values at one or more electrodes of the electrode array, within a region of tissue, during the active treatment session;

determining impedance changes of tissue beneath skin surface under one or more electrodes of the electrode array using one or more of the measured impedance values within the region of tissue to obtain an impedance mapping of the region of tissue, wherein the signal transmission path having the length Y is a conductive trace on a printed circuit board, configured to improve the impedance mapping and reduce cross coupling below a threshold level,

determining one or more temperatures of a tissue beneath the skin surface under one or more electrodes of the electrode array using the determined impedance changes,

wherein the determined impedance changes are proportional to temperature changes in the tissue; and

controlling activation and deactivation of a plurality of electrodes of the electrode array during the active treatment session to achieve substantially uniform treatment of the tissue region using the impedance mapping and the determined temperature in response to one or more determined temperatures.

27 . The method of claim 26 , wherein the active treatment session is a selective tissue coagulation session, wherein the electrode array is controlled to direct RF energy for selective tissue coagulation treatment.

28 . The method of claim 26 , wherein the active treatment session is a skin tightening treatment session, wherein the electrode array is controlled to direct RF energy for skin tightening treatment.

29 . The method of claim 26 further comprising reducing edge effects at periphery of one or more electrodes in the electrode array by grouping electrodes of the electrode array into clusters and selectively controlling the activation and deactivation of the clusters.

Assignments (10)

Continuity (4)

References Cited (349)